← Open Payments lookup

AUDREY LASTRA: Open Payments

NPI 1104105600 · NEW HAVEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,625 in 122 payments from 21 companies in 2025. Trend: 2023 $2,058 · 2024 $3,930 · 2025 $5,625

Food & beverage: $3,988Consulting: $1,560Education: $77
CompanyPaymentsAmount
Janssen Biotech, Inc.13$1,995
Madrigal Pharmaceuticals7$686
ABBVIE INC.26$501
Phathom Pharmaceuticals, Inc.14$427
Takeda Pharmaceuticals U.S.A., Inc.11$330
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$317
Ardelyx, Inc.11$309
Regeneron Healthcare Solutions, Inc.4$198
Novo Nordisk Inc2$156
GENZYME CORPORATION6$142

Products named: TREMFYA, REZDIFFRA, VOQUEZNA, DUPIXENT, IBSRELA, XIFAXAN, ENTYVIO, Wegovy.

Industry payments across CT — which companies pay providers there.